Tackling CD147 exosome-based cell-cell signaling by electrochemical biosensing for early colorectal cancer detection
Loading...
Official URL
Full text at PDC
Publication date
2022
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Citation
Víctor Pérez-Ginés, Rebeca M. Torrente-Rodríguez, Ana Montero-Calle, Guillermo Solís-Fernández, Pablo Atance-Gómez, María Pedrero, José M. Pingarrón, Rodrigo Barderas, Susana Campuzano, Tackling CD147 exosome-based cell-cell signaling by electrochemical biosensing for early colorectal cancer detection, Biosensors and Bioelectronics: X, Volume 11, 2022, 100192, ISSN 2590-1370, https://doi.org/10.1016/j.biosx.2022.100192.
Abstract
The great opportunities represented by exosomes in liquid biopsy diagnostics and the relevance of CD147 protein
as diagnostic and prognostic cancer biomarker led us to develop the first bio-electroanalytical platform for the
determination of exosomal CD147 (exoCD147) by exploiting micro-sized magnetic beads coated with specific
anti-CD147 antibodies. The captured exosomal target protein was sandwiched by specific biotin functionalized
detector antibodies followed by attaching streptavidin-HRP conjugate to perform the amperometric reading
using screen-printed carbon electrodes (SPCEs) as electrode transducers in the presence of hydroquinone (HQ)
and H2O2. The analytical and operational characteristics achieved by implementing this simple methodology
allowed the sensitive (LOD 29 pg mL− 1
) and selective determination of CD147 and the analysis of exoCD147 in
different but inter-related real clinical scenarios including lysed and entire exosomes previously isolated from
CRC cell lines with different metastatic potential. The obtained results, in agreement with those provided by
ELISA and WB, proved the reliability of the developed immunosensor and its potential to isolate or identify
specific subpopulations of exosomes based on the differential expression of characteristic surface biomarkers.